Clinical Trials
3 trialsNCT07042295 2026-05-27
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
National Cancer Institute (NCI)
Phase 2 Suspended
NCT06102902 2026-05-13
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
National Cancer Institute (NCI)
Phase 1 Suspended
NCT05200442 2026-05-08
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer
University of Chicago
Phase 1/2 Suspended